Home/Filings/4/0000899243-19-002250
4//SEC Filing

BlueMountain Capital Management, LLC 4

Accession 0000899243-19-002250

CIK 0001616314other

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 4:50 PM ET

Size

22.6 KB

Accession

0000899243-19-002250

Insider Transaction Report

Form 4
Period: 2019-01-29
Transactions
  • Sale

    Common Stock

    2019-01-29$11.35/sh1,902$21,588290,261 total(indirect: Footnotes)
  • Sale

    Common Stock

    2019-01-29$11.27/sh25,000$281,750265,261 total(indirect: Footnotes)
  • Sale

    Common Stock

    2019-01-29$11.30/sh50,000$565,000215,261 total(indirect: Footnotes)
  • Sale

    Common Stock

    2019-01-29$11.24/sh25,000$281,000165,261 total(indirect: Footnotes)
  • Sale

    Common Stock

    2019-01-30$11.45/sh15,000$171,750150,261 total(indirect: Footnotes)
  • Sale

    Common Stock

    2019-01-29$11.28/sh25,000$282,000190,261 total(indirect: Footnotes)
  • Sale

    Common Stock

    2019-01-30$11.38/sh25,000$284,500125,261 total(indirect: Footnotes)
  • Sale

    Common Stock

    2019-01-30$11.35/sh25,000$283,750100,261 total(indirect: Footnotes)
  • Sale

    Common Stock

    2019-01-30$11.31/sh25,000$282,75075,261 total(indirect: Footnotes)
Footnotes (4)
  • [F1]The filing of this Form 4 shall not be construed as an admission that BlueMountain Capital Management, LLC ("BMCM") is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any of the shares of Common Stock, par value $0.01 per share (the "Common Stock"), of MedEquities Realty Trust, Inc. (the "Issuer"). Pursuant to Rule 16a-1(a)(4) of the Exchange Act, BMCM disclaims such beneficial ownership, except to the extent of its pecuniary interest.
  • [F2]BMCM is the investment manager of Blue Mountain Credit Alternatives Master Fund L.P. ("BMCA"), BlueMountain Guadalupe Peak Fund L.P. ("BMGP"), BlueMountain Credit Opportunities Master Fund I L.P. ("BMCO"), BlueMountain Strategic Credit Master Fund L.P. ("BMSC") and BlueMountain Montenvers Master Fund SCA SICAV-SIF ("BMM" and, together with BMCA, BMGP, BMCO and BMSC, the "Funds"), which are the direct beneficial owners of 75,261 shares of Common Stock in the aggregate. BMCM, although it directs the voting and disposition of the Common Stock held by the Funds, only receives an asset-based fee relating to the Common Stock held by the Funds.
  • [F3]On January 29, 2019, BMCA, BMGP, BMCO, BMSC and BMM sold 529, 118, 529, 198 and 528 shares of Common Stock, respectively, for $11.35 per share, 6,948, 1,554, 6,949, 2,600 and 6,949 shares of Common Stock, respectively, for $11.27 per share, 13,898, 3,107, 13,897, 5,199 and 13,899 shares of Common Stock, respectively, for $11.30 per share, 6,949, 1,554, 6,949, 2,600 and 6,948 shares of Common Stock, respectively, for $11.28 per share, and 6,948, 1,554, 6,949, 2,599 and 6,950 shares of Common Stock, respectively, for $11.24 per share.
  • [F4]On January 30, 2019, BMCA, BMGP, BMCO, BMSC and BMM sold 4,169, 932, 4,169, 1,560 and 4,170 shares of Common Stock, respectively, for $11.45 per share, 6,948, 1,553, 6,949, 2,600 and 6,950 shares of Common Stock, respectively, for $11.38 per share, 6,949, 1,554, 6,948, 2,600 and 6,949 shares of Common Stock, respectively, for $11.35 per share, and 6,949, 1,554, 6,949, 2,599 and 6,949 shares of Common Stock, respectively, for $11.31 per share.

Issuer

MedEquities Realty Trust, Inc.

CIK 0001616314

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001427430

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:50 PM ET
Size
22.6 KB